5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The France Aesthetic Medicine Market has been segmented by Product (Botulinum Toxin, Dermal Filler, Chemical Peel, and Microdermabrasion) and End User (Diagnostic Centers, Hospitals, and Other End Users).
Key factors propelling the growth of the market are the growing adoption of non-invasive aesthetic procedures, increasing awareness among customers, and the availability of user-friendly aesthetic products.
In France, it has been observed that patients begin anti-aging techniques and minimally-invasive treatments at a very young age, and require more invasive procedures to maintain their youthful appearance. Moreover, the rise in disposable income has boosted the demand for cosmetic surgeries, thereby, accelerating the market growth.
Along with the increased awareness about the potential benefits of aesthetic procedures, people are also inclined toward the use of minimal or non-invasive procedures in aesthetic treatments. The popularity of non-invasive or minimally invasive techniques is increasing in France. The reason for significant inclination is that majority of the audiences perceive normal surgical treatments as painful and with high risk factors. Thus, the growing adoption of non- or minimally-invasive aesthetic procedures is fueling the growth of the French aesthetic medicine market.
Additionally, there has been an abundant rise in advertising, displaying the ‘before’ and ‘after’ difference of various aesthetic procedures, thereby, prompting the youth and middle-aged to undergo medical aesthetic procedures.
As per the scope of the report, aesthetic medicine is defined as the specialties that focus on enhancing cosmetic appearance through the treatment of aging, infectious, or diseased skin conditions. Aesthetic medicines and cosmetic surgeries are developing clinical subspecialty and field in scientific research, which comprise all kinds of medical procedures whose purpose is to improve the physical appearance of the patients, including all non-invasive and minimally-invasive cosmetic procedures.
|By End User|
|Other End Users|
Report scope can be customized per your requirements. Click here.
To understand key trends, Download Sample Report
The French aesthetic medicine market is fairly consolidated, with some local players competing with international players. Major strategies adopted by most of the key industry players include new product launches, acquisitions, mergers, and partnerships, to strengthen the aesthetics product portfolio and maintain their market positioning.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Adoption of Non- and Minimally-Invasive Aesthetic Procedures
4.2.2 Increasing Awareness among Customers about Cosmetic Procedures
4.2.3 Availability of User-friendly Aesthetic Products
4.3 Market Restraints
4.3.1 Stringent Safety Regulations for Aesthetic Procedures
4.3.2 Risk of Side Effects
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Product
5.1.1 Botulinum Toxin
5.1.2 Dermal Filler
220.127.116.11 Absorbable Dermal Filler
18.104.22.168 Non-absorbable Dermal Filler
5.1.3 Chemical Peel
5.2 By End User
5.2.1 Diagnostic Centers
5.2.3 Other End Users
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Allergan PLC
6.1.2 Bioxis Pharmaceuticals
6.1.3 Dermaceutic Laboratoire
6.1.4 Ipsen Pharma
6.1.5 Johnson & Johnson
6.1.6 Nestle Skin Health
6.1.7 Merz Pharma GmbH & Co. KGaA
6.1.8 Laboratoires Filorga
6.1.9 Teoxane Laboratories
6.1.10 Laboratories Vivacy
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments